Close Menu
Home » Epic Sciences' Circulating Tumor Cell Prostate Cancer Test Shows Promise in New JAMA Study

Epic Sciences' Circulating Tumor Cell Prostate Cancer Test Shows Promise in New JAMA Study

Jun 06, 2016
|
Molika Ashford
Premium

CHICAGO (GenomeWeb) – A new study by researchers from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR-V7 protein expression test using Epic Sciences' non-EPCAM-based circulating tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration-resistant prostate cancer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Harvard Prof Charged

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

But What About That Preserved Frog Smell?

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Level of Transparency

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

PNAS Papers Describe Amish De Novo Mutation Decrease, RNA Sequencing Method, Precision Med Results

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In Molecular Diagnostics

  1. CDC Provides Test Protocol for Novel Coronavirus, Preps Kits for Local Use

  2. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  3. Whole-Genome Sequencing, Deep Phenotyping Shows Many Adults Harbor Pathogenic Genetic Variants

  4. CMS to Cover FDA-Approved, -Cleared NGS Germline Tests for Breast, Ovarian Cancer Patients

  5. Colon Cancer Biomarker Undertesting Rates in Real-World Data Points to Precision Oncology Barriers

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.